(Q37036723)

17 August 2017

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal (English)

1 reference

17 August 2017

phase III clinical trial

0 references

0 references

0 references

8

Marian W Fischman

1 reference

17 August 2017

Elmer Yu

1

1 reference

17 August 2017

Karen Miotto

2

1 reference

17 August 2017

Evaristo Akerele

3

1 reference

17 August 2017

Ann Montgomery

4

1 reference

17 August 2017

Ahmed Elkashef

5

1 reference

17 August 2017

Robert Walsh

6

1 reference

17 August 2017

Ivan Montoya

7

1 reference

17 August 2017

Joseph Collins

9

1 reference

17 August 2017

Frances McSherry

10

1 reference

17 August 2017

Kathy Boardman

11

1 reference

17 August 2017

David K Davies

12

1 reference

17 August 2017

Charles P O'Brien

13

1 reference

17 August 2017

Walter Ling

14

1 reference

17 August 2017

Herbert Kleber

15

1 reference

17 August 2017

Barbara H Herman

16

1 reference

17 August 2017

27 May 2008

1 reference

Drug and Alcohol Dependence

17 August 2017

1 reference

17 August 2017

97

1 reference

17 August 2017

1-2

1 reference

17 August 2017

158-168

1 reference

Religiosity and violence among adolescents in the United States: findings from the national survey on drug use and health 2006-2010.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Alpha2 adrenergic agonists for the management of opioid withdrawal

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Combating opiate dependence: a comparison among the available pharmacological options

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Alpha2-adrenergic agonists in opioid withdrawal

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

A Multiple Testing Procedure for Clinical Trials

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Clonidine and the treatment of the opiate withdrawal syndrome

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Pharmacological advances in addiction treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Local opiate withdrawal in locus coeruleus in vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Signs and symptoms of tobacco withdrawal.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: co-localization and interactions during withdrawal.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Delineation of three pharmacological subtypes of α2-adrenoceptor in the rat kidney

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

A 33-year follow-up of narcotics addicts

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Opiate detoxification using lofexidine.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Two New Rating Scales for Opiate Withdrawal

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613766

Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide

4 December 2018

1 reference

12 December 2020

Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal

1 reference

12 December 2020

Dorsal root lesions block the expression of morphine withdrawal elicited from the rat spinal cord

1 reference

12 December 2020

Characterization of central alpha-adrenoceptors using 3H-clonidine and its derivatives

1 reference

12 December 2020

The use of lofexidine by drug dependency units in the United Kingdom

1 reference

12 December 2020

Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

1 reference

12 December 2020

Opiate detoxification with lofexidine

1 reference

12 December 2020

The development of a Short Opiate Withdrawal Scale (SOWS)

1 reference

12 December 2020

Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat

1 reference

12 December 2020

Clonidine in outpatient detoxification from methadone maintenance

1 reference

12 December 2020

Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding

1 reference

12 December 2020

10.1016/J.DRUGALCDEP.2008.04.002

Identifiers

DOI

1 reference

release_3yblyhihizarpa3ryxoqjmzby4

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3yblyhihizarpa3ryxoqjmzby4

24 November 2022

mapped directly with Wikidata item

1 reference

17 August 2017

1 reference